Semaglutide is a GLP-1 receptor agonist available for research purposes only. It has shown significant potential in clinical studies for appetite suppression, weight loss, and blood sugar regulation. Available in 10mg, 20mg, and 30mg, this flexible dosing makes it an excellent option for researchers studying metabolic and weight loss treatments.

Key Benefits:

• For research purposes only
• Effective for appetite suppression and metabolic regulation
• Flexible dosing options (10mg, 20mg, 30mg)
• Affordable and accessible for scientific studies